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Abstract 
Background: Post endoscopic sclerotherapy esophageal stricture is usually not fatal but may 
requires several sessions of esophageal dilation as an effective palliative treatment yet has its own 
complications. 
Aim:  The purpose of this study is to find out the predictors of sclerotherapy esophageal stricture.  
Methods: This is a cross sectional descriptive study of the esophageal stricture post sclerotherapy 
for the patients who were managed in the period from January 2000 through the June 2007 in 
endoscopic department at Ibn Sina Hospital. Post endoscopic sclerotherapy symptoms, signs, 
diagnostic and therapeutic methods were analysed to find out possible predictors of developing 
benign esophageal stricture.  
Result: A 33 out of 10133 patients who had sclerotherapyl were found to have esophageal stricture 
and were included in this study. 91% of them were males, 88% were <60years old and most of them 
were cases of hepatic periportal fibrosis. Only two patients had esophageal varices secondary to 
viral hepatitis B liver cirrhosis. Their presentation was commonly with difficulty in swallowing and 
few cases presented with food impaction. The majority of patients were treated with wire guided 
endoscopic Savary Gilliard dilation. 
Conclusion: Esophageal stricture following endoscopic injection sclerotherapy is a known 
morbidity; however the rate of these strictures is fairly acceptable. High dose of sclerotherapy in 
fewer sessions over a short period are potential predictors of esophageal stricture. 
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bn Sina Hospital is a specialized referral 
tertiary hospital directly supervised by the 
National Gastrointestinal and Liver 
Diseases Centre (NGLC) in Khartoum, 
Sudan. The endoscopic department in Ibn 
Sina Hospital (ISH) and Mohammed Salih 
Idris’s Centre for Gastrointestinal Bleeding is 
the largest referral centre for both elective and 
emergency gastro-intestinal (GI) bleeders in 
the Sudan. In seven years (2001-2007) 10133 
patients had sclerotherapy. Those who were 
managed electively with endoscopic injection 
sclerotherapy (EIS) in two years (2006-2007) 
were 3557patients.  
The acquired benign esophageal stricture 
(BES) is a common complication which may 
follow many esophageal disorders, such as 
gastro -  esophageal    reflux,   ingestion   of 
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corrosive agents, esophageal surgery, 
radiotherapy, post-endoscopic variceal 
sclerotherapy, drug ingestion, prolonged 
naso-gastric intubation, and extrinsic 
compression 1,2 
BES following EIS is usually not fatal but 
may require frequent dilation of the 
esophagus which itself is not without 
complications.  
Aims: To find out the predictors of post EIS 
esophageal stricture. 
Patients and methods: This is a cross-
sectional hospital based descriptive study of 
the esophageal stricture post-EIS for patients 
treated in the period from January 2000 
through June 2007. Medical records of 
patients who had sclerotherapy during that 
period were retrieved and biomedical data 
were collected. Post EIS symptoms, signs, 
diagnostic procedures and methods of 
treatment were noted and analyzed to find 
possible predictors for developing post-EIS 
esophageal stricture. 
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Out of 10133 patients who underwent 
sclerotherapy in the mentioned period only 33 
had stricture and were included in this study. 
30 of these were males (91%). Most of the 
patients belong to the young adult age group 
as shown in table1. Esophageal varices 
resulted from portal hypertension secondary 
to periportal fibrosis which is commonly due 
to Bilharziasis in the Sudan. However, two 
cases of portal hypertension were secondary 
to post hepatitis B liver cirrhosis (table 1). 
 












M F PPF LC  No SD SD 
10-19 1 1 2   2 
20-29 1 1 2   2 
30-39 7 1 7 1 2 6 
40-49 7  7   7 
50-59 10  10  1 9 
60+ 3  3   3 
unknown 1   1 1  
Total  33 patients 
LC=liver cirrhosis, SD= Savary-Gilliard 
dilation 
 
Ethanolamine oleate 5% was used for EIS in 
all (97%) apart from one (3%) patient who 
was injected with Sodium Tetradycyl Sulfate 
(STDS). 
Post EIS presentations were difficulty in 
swallowing in all cases. The duration of 
treatments before stricture development was 
illustrated in table 2.  
Endoscopic findings showed various degrees 
of esophageal strictures. The majority of 
patients were then treated with endoscopic 
Savary-Gilliard dilation (SD). Fluoroscopy 
was not required during these procedures. The 
largest group (12 patients) of patients 
developed BES in < 6 months while another 
large group (9 patients) had it in> 36 months.  
Discussion: In this study 10133 patients had 
EIS on regular basis. They had a total number  
 
 
of 30399 sessions (mean number of sessions 
of sclerotherapy was 3) only 33 patients 
developed post-sclerotherapy esophageal 
stricture. So, among our patients the chances 
for eveloping post-sclerotherapy stricture was 
around 0.3%. On the other hand, in one local 
study3 the rate of post EIS strictures was 
2.9%.  The relatively larger sample size in our 
study gives it more weight. Also, our results 
were augmented by the reasonable 
improvement in documentation of the 
patients' data, which were computerised in the 
Statistics Department at Ibn Sina Hospital.   
Post EIS stricture presentation was difficulty 
in swallowing in all our cases which is similar 
to literature4.  
The majority (88%) of our patients were <60 
years old. This is because most of our patients 
were productive young farmers suffering of 
esophageal varices as a consequence of portal 
hypertension secondary to Bilharzial 
periportal fibrosis in the major agricultural 
schemes in Zaidab, Gazeera area, Rahad, 
Halfa Elgadeeda Irrigation Schemes. This fact 
is in keeping with results of other local 
studies5.  
All cases with stigmata of chronic liver 
disease were screened for hepatitis B and C. 
HBsAg was reported previously to affect 
between 5.1% - 10%5-7 of patients, going with 
that we found two (6%) out of 33 post-
sclerotherapy esophageal stricture patients to 
have liver cirrhosis secondary to viral B 
hepatitis. This could be supported by the fact 
that few percentage (<5%) of patients who 
contract HBV infection in adult hood will not 
clear the virus. However more sensitive tests 
and liver biopsies are required to verify the 
true percentage of patients with bleeding 
varices due to chronic HBV infection alone or 
concomitant with Bilharzial periportal 
fibrosis.  
The endemicity of Bilharzia and its 
complications especially the periportal 
fibrosis with the consequences of upper GIT 
bleeding that has high mortality and 
morbidity should trigger the re-evaluation and 
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Table2: Development of stricture in relation to sex, time, and dose of sclerothrapy.  
 
reconsideration of the cost-effectiveness of 
the above mentioned agricultural schemes. 
Intensive Bilharzial eradication measures 
(WHO system) including biological, chemical 
and mechanical measures should be applied to 
these areas to reduce the negative impact of 
these schemes on the citizens. Not only that; 
but we advocate for early health planning, 
public medical education, eradication 
measures which should be strictly and firmly 
applied to the newly constructed agricultural 
schemes in the Northern and River Nile States 
particularly El Hamdab and El Silaim, 
agricultural schemes to avoid the catastrophic 
consequences of Bilharzia.       
For sclerotherapy we used ethanolamine 
oleate 5%, which is prepared in our local 
pharmacy, and therefore it is cheap and 
available. In contrast, international studies 
showed that there is no significant difference 
in efficacy or complication with regard to the 
substance used being absolute alcohol, 
ethanolamine oleate, or  sodium tetradycyl 
sulfate 8. 
The duration and dosage of sclerotherapy 
before development of strictures was variable 
(Table 2). However, it is clear in this study 
that esophageal stricture development has two 
peaks. The 1st one included the largest group 
(12) and had it in less than six months of 
sclerotherpy; all of these patients had <4 
sessions of therapy and the larger the dose 
per-session (e.g. 57.8) the more likely the 
development of stricture, while the 2nd peak 
occurred later   (>36 months) and a gain the 
stricture was more in those who had larger 
doses of slerosing agent. This finding is 
consistent with reports from Japan4. 
 Both intra-variceal and para-variceal 
injections are effective for controlling and 
preventing future bleeding from esophageal 
varices. However, as in the majority of 
interventional methods of treatment it is 
probably not easy to randomise patients for 
intra-variceal and para-variceal injections to 
find out the impact of these particular 
methods on development of esophageal 






























1-2  50 -100 50 - 1 - - - - - 1 
3-4  50 -100 21.43 - - - - - - 1 1 
7 plus > 100 14.28 - - - - - - 1 1 
M. 
1-2  
Not reg.  1 - - - - - - 1 
< 50 33.33 1 3 - 1 - 1 - 6 
50 -100 57.8 - 4 - - - - - 4 
3-4  < 50 
14.28 - 1 - - - - - 1 
50 -100 21.43 - 3 3 1 - - 1 8 
5- 6 
Not reg.  1 - - - - - - 1 
< 50 9.09 - - - 1 - - - 1 
50 -100 13.6 - - - - - - 2 2 
>100ml 18.18 - - - - - - 2 2 
7 plus 
< 50 7.14 - - - - - - 1 1 
50 -100 10.71 - - - - - 1 - 1 
> 100 14.28 - - - - 1 - - 1 
Not reg. 50 -100  - - - - - - 1 1 
Total    3 12 3 3 1 2 9 33 
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should be applied in a spiral fashion starting 
at the distal end of the esophagus. 
Conversely, circumferential injection 
particularly dictated by the active bleeding 
may lead to esophageal stricture9. Also, the 
length of the tip of the needle passing into the 
submucosa of the esophagus or its muscularis 
propria may create severe inflammatory 
reaction and necrosis ending in stricture or 
delayed perforation of the esophagus. To save 
guard against this, the injecting doctor should 
make sure- as possible as he can- that he is 
injecting either intra-variceal or para-variceal 
in the sub-mucosa and should not push in the 
needle hard to reach the muscularis propria. 
In this retrospective study it was difficult to 
identify the site and depth of the injections.       
For the management of bleeding esophageal 
varices EIS is feasible, safe, effective and cost 
effective in comparison to band ligation or 
surgery which cost 300 Sudanese Pound (SP) 
per session and 2000 SP (150-1000 US$) 
respectively while EIS costs only 50-70 
SP(20-30 US$) per session. Nevertheless, it is 
important to state that centres providing this 
kind of treatment should be in proximal 
vicinity i.e. in regional hospitals within the 
agricultural schemes in order to reduce the 
cost of the procedure and also reduce the load 
on the referral treating centres.      
Conclusion:  Esophageal stricture is a known 
morbidity following EIS. However the rate of 
this stricture is fairly acceptable. The larger 
the dose of sclerosing agent per-session, the 
greater the chance of developing stricture. 
The potential predictor mentioned 
necessitates further multi-centric and 
prospective studies for clarification and also 
for formulation of national guidelines for 
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